VALUE OF ITALIAN PHARMA INDUSTRY HITS HISTORIC HIGH IN 2016
Medicines manufactured by the Italian pharmaceutical industry were worth a total of €30 billion in 2016, rising 2.3% from 2015 to a historic high, data from sector association Farmindustria showed. Exports were worth €21 billion (71% of production), up 52% compared to 2010. Employment increased 9%, or by 6,000 people, investments reached €2.7 billion (+20% in three years). The year 2017 started positively: between January and April production rose 4.7%, exports were up 14% and employment rose 2.7%.
This picture of the sector was illustrated during Farmindustria's assembly yesterday. This was an occasion for the pharmaceutical industries that operate in Italy to showcase the potential of the sector and to claim a leading role in the 4.0 industrial innovation which is revolutionizing the health industry, also in Italy.
Pharmaceutical companies highlighted that per-capita public spending on medicines in Italy is worth 80 cents a day for every citizen, 29% less than the EU average, and prices are on average 15% lower than those of European competitors.
A true revolution is on the way in the trend toward personalized and “intelligent” treatment in the pharmaceuticals world. Firms are set to become “solution companies” offering integrated solutions with a strong convergence between pharmaceuticals and information and communications technology: from medicines that free an active ingredient when it is needed during the month, to the measurement of glucose levels through contact lenses equipped with biosensors connected to an app.
It is a time of great challenges, underlined Farmindustria President Massimo Scaccabarozzi: “to overcome them, the pharmaceuticals industry is calling for a new pact with the institutions to reinforce the one signed four years ago which brought investment, research and employment to Italy.”
The pharmaceuticals industry in Italy is asking to review this accord in light of the fast-moving revolutions in the digital sphere and in personalized medicine.
“Today, the pharmaceuticals industry is, as everyone is saying, a strategic asset of the country,” said the Farmindustria president. “There is one more mile to go to reach a new governance. That is to be walked alongside institutions, patients, and doctors.”